Lymphoma in China
Overview
Lymphoma is a cancer of the lymphatic system, divided into Hodgkin and many non-Hodgkin subtypes. Accurate pathological subtyping drives everything: some lymphomas are cured with limited therapy, others need intensive immunochemotherapy or cellular therapy.
Chinese lymphoma centers run dedicated pathology units and high-volume immunochemotherapy programs, with CAR-T options for relapsed refractory B-cell disease.
Symptoms & Signs
Painless swollen lymph nodes in the neck, armpit or groin
Persistent fatigue and unexplained fevers or drenching night sweats
Unintentional weight loss exceeding 10% of body weight
Itching without rash, occasionally severe
Cough or breathlessness from chest disease; abdominal fullness from nodes or spleen
Some indolent lymphomas are monitored for years without symptoms requiring treatment
Diagnosis
Excisional lymph node biopsy — the essential diagnostic step, providing full architecture
Expert pathology review with immunohistochemistry and flow cytometry
PET-CT for staging and response assessment
Marrow biopsy evaluating involvement
Molecular and cytogenetic studies classifying subtype
Lumbar puncture for subtypes with central-nervous-system risk
Treatment Options
Immunochemotherapy (anti-CD20 antibody combined with chemotherapy) for aggressive B-cell lymphoma
Limited-field radiotherapy for early-stage Hodgkin and selected indolent lymphomas
Watch-and-wait with scheduled review for asymptomatic indolent disease
High-dose chemotherapy with autologous stem-cell rescue for relapsed aggressive disease
CAR-T cell therapy for relapsed refractory large B-cell lymphoma
Novel agents — BTK inhibitors, PI3K inhibitors, bispecific antibodies — for relapsed mantle-cell, follicular and other subtypes
Advanced Technologies & Novel Drug
Expert hematopathology with molecular subtyping
PET-CT response-adapted treatment strategies
CAR-T manufacturing and infusion programs
Bispecific antibody therapy available at major centers
Novel BTK inhibitors and targeted agents approved in China for multiple subtypes
Hospital & Specialist
- Cancer Hospital, Chinese Academy of Medical Sciences (CICAMS) — Beijing
- Peking University People's Hospital — Beijing
- Sun Yat-sen University Cancer Center (SYSUCC) — Guangzhou
- Hospital of Hematology, Chinese Academy of Medical Sciences — Tianjin
- Li Jun Ling — Medical Oncology
- Wang Xing Yuan — Medical Oncology
- Zhang Xiao Shi — Medical Oncology
- Lin Tong Yu — Medical Oncology